Growth Metrics

Palvella Therapeutics (PVLA) Net Cash Flow (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palvella Therapeutics 1.47 Bn 1.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3,086.34%
Dec 31, 2025 34.94%
Sep 30, 2025 -50.27%
Jun 30, 2025 36.22%
Mar 31, 2025 -111.49%
Dec 31, 2024 37,010.64%
Sep 30, 2024 -101.80%
Jun 30, 2024 32.50%
Mar 31, 2024 -13.35%
Dec 31, 2023 177.86%
Sep 30, 2023 -334.89%
Jun 30, 2023 449.50%
Mar 31, 2023 107.73%
Dec 31, 2022 -287.74%
Sep 30, 2022 88.43%
Jun 30, 2022 20.80%
Mar 31, 2022 -417.35%
Dec 31, 2021 -190.16%
Sep 30, 2021 -86.46%
Jun 30, 2021 2,214.60%
Mar 31, 2021 -263.88%
Dec 31, 2020 -92.60%
Sep 30, 2020 641.82%
Jun 30, 2020 74.41%
Mar 31, 2020 -193.09%
Dec 31, 2019 290.30%
Sep 30, 2019 -437.86%
Jun 30, 2019 112.04%
Mar 31, 2019 -43.15%
Dec 31, 2018 -136.29%
Sep 30, 2018 168.16%
Jun 30, 2018 -181.01%
Mar 31, 2018 245.79%
Dec 31, 2017 -232.22%
Sep 30, 2017 745.77%
Jun 30, 2017 -122.35%
Mar 31, 2017 467.35%
Dec 31, 2016 -81.75%
Sep 30, 2016 -142.06%
Jun 30, 2016 365.33%
Mar 31, 2016 169.12%
Dec 31, 2015 -112.85%
Sep 30, 2015 797.55%
Jun 30, 2015 33.63%
Sep 30, 2014 98.85%
Jun 30, 2014 -420.99%
Mar 31, 2014 -64,493.40%
Dec 31, 2013 114.45%
Sep 30, 2013 -186.77%